UB Paderborn / Katalog / Suche / in CDI

Publisher Correction to: Safety, effectiveness and mid-term follow-up in 136 consecutive patients with moderate to severely calcified lesions undergoing phoenix atherectomy

Heart and vessels, 2022-04, Vol.37 (4), p.711-711

2022

Link zum Volltext

Verfügbarkeit prüfen

Truncating mutations in the Wilson disease gene ATP7B are associated with very low serum ceruloplasmin oxidase activity and an early onset of Wilson disease

BMC gastroenterology, 2010-01, Vol.10 (1), p.8-8, Article 8

2010

Link zum Volltext

Verfügbarkeit prüfen

Outcomes and Costs of Treating Hepatitis C Patients in the Era of First Generation Protease Inhibitors - Results from the PAN Study

PloS one, 2016-07, Vol.11 (7), p.e0159976

2016

Link zum Volltext

Verfügbarkeit prüfen

Changes in severity of influenza A(H1N1)pdm09 infection from pandemic to first postpandemic season, Germany

Emerging infectious diseases, 2013-05, Vol.19 (5), p.748-755

2013

Link zum Volltext

Verfügbarkeit prüfen

Sensitivity and specificity of plasma disappearance rate of indocyanine green as a prognostic indicator in acute liver failure

BMC gastroenterology, 2009-12, Vol.9 (1), p.91-91, Article 91

2009

Link zum Volltext

Verfügbarkeit prüfen

Chronic hepatitis E virus infection in a patient with leukemia and elevated transaminases: a case report

Journal of medical case reports, 2012-10, Vol.6 (1), p.334-334, Article 334

2012

Link zum Volltext

Verfügbarkeit prüfen

Fatal Course of a Suicidal Intoxication with Hydrochloric Acid

Case reports in gastroenterology, 2013-03, Vol.7 (1), p.89-96

2013

Link zum Volltext

Verfügbarkeit prüfen

Diagnostic Pathway From Incidental Mass to Metastatic Melanoma: Role of Multimodal Imaging and Medical Therapy

JACC. Case reports, 2024-01, Vol.29 (1), p.102146

2024

Link zum Volltext

Verfügbarkeit prüfen

Diagnostic Pathway From Incidental Mass to Metastatic Melanoma

JACC. Case reports, 2024-01, Vol.29 (1), p.102146, Article 102146

2024

Link zum Volltext

Verfügbarkeit prüfen

HFE Gene Mutations, Iron Overload and Cryptogenic Liver Cirrhosis

Hepatitis monthly, 2012-03, Vol.12 (3), p.209-210

Eisenbach, Christoph

2012

Link zum Volltext

Verfügbarkeit prüfen

Changes in severity of influenza Apdm09 infection from pandemic to first postpandemic season, Germany

Emerging infectious diseases, 2013-05, Vol.19 (5), p.748

2013

Link zum Volltext

Verfügbarkeit prüfen

Pharmacodynamic monitoring of immunosuppressive effects indicates reduced cyclosporine activity during telaprevir therapy: NFAT in Liver Allograft Recipients on Telaprevir

Liver transplantation, 2014-09, Vol.20 (9), p.1106-1117

2014

Link zum Volltext

Verfügbarkeit prüfen

An orthotopic colon cancer model for studying the B7-H3 antitumor effect in vivo

Journal of gastrointestinal surgery, 2006-05, Vol.10 (5), p.635-645

2006

Link zum Volltext

Verfügbarkeit prüfen

723 Substantial Renal Impairment Is Not Infrequent in HCV Patients Under Triple Therapy With Telaprevir or Boceprevir

Gastroenterology (New York, N.Y. 1943), 2013-05, Vol.144 (5), p.S-960-S-960

2013

Link zum Volltext

Verfügbarkeit prüfen

Outbreak of Nosocomial Respiratory Syncytial Virus Infections in a Hematology and Transplant Unit

Blood, 2012-11, Vol.120 (21), p.3032-3032

2012

Link zum Volltext

Verfügbarkeit prüfen

Sa1050 Efficacy of Boceprevir Based Triple Therapy in Combination With Peginterferon-Alfa-2A Plus Ribavirin (P/R) Under Real Life Conditions in Treatment Experienced Patients Infected With Chronic Hepatitis C, Genotype 1: The PAN Study

Gastroenterology (New York, N.Y. 1943), 2013-05, Vol.144 (5), p.S-982-S-982

2013

Link zum Volltext

Verfügbarkeit prüfen

Sa1041 Triple Therapy Under Real Life Conditions: Telaprevir (TVR) and Boceprevir (BOC) in Combination With Peginterferon-Alfa-2A Plus Ribavirin (P/R) in Treatment Experienced Patients Infected With Chronic Hepatitis C, Genotype 1. the PAN Study

Gastroenterology (New York, N.Y. 1943), 2013-05, Vol.144 (5), p.S-980-S-980

2013

Link zum Volltext

Verfügbarkeit prüfen

Sa1051 Boceprevir Based Triple Therapy in Combination With Peginterferon-Alfa-2A Plus Ribavirin (P/R) Under Real Life Conditions in Treatment NaïVE Patients Infected With Chronic Hepatitis C, Genotype 1: An Interim Analysis At Week 12 After Start of Treatment

Gastroenterology (New York, N.Y. 1943), 2013-05, Vol.144 (5), p.S-982-S-983

2013

Link zum Volltext

Verfügbarkeit prüfen

Sa1052 Triple Therapy Under Real Life Conditions: Telaprevir (TVR) in Combination With Peginterferon-Alfa-2A Plus Ribavirin (P/R) in NaïVE Patients Infected With Chronic Hepatitis C, Genotype 1. The PAN Study

Gastroenterology (New York, N.Y. 1943), 2013-05, Vol.144 (5), p.S-983-S-983

2013

Link zum Volltext

Verfügbarkeit prüfen

Sa1058 Change of Treatment Patterns Over a Decade of Dual Therapy of Chronic Hepatitis C (CHC) With Peginterferon Alfa-2A (PEG) and Ribavirin (RBV)

Gastroenterology (New York, N.Y. 1943), 2012-05, Vol.142 (5), p.S-957-S-958

2012

Link zum Volltext

Verfügbarkeit prüfen

Sa1059 Viral Response at Week 2 as a Predicitive Factor for Rvr in Chronic Hepatitis C Genotype 1 Infection Treated With Peginterferon Alfa-2A (PEG) and Ribavirin (RBV)

Gastroenterology (New York, N.Y. 1943), 2012-05, Vol.142 (5), p.S-958-S-958

2012

Link zum Volltext

Verfügbarkeit prüfen

Dose Reduction of Peginterferon Alfa-2a (PEG) in Combination With Ribavirin (RBV) in Chronic Hepatitis C (CHC) Patients: Impact on Virological Response Under Real Life Conditions

Gastroenterology (New York, N.Y. 1943), 2011, Vol.140 (5), p.S-948-S-948

2011

Link zum Volltext

Verfügbarkeit prüfen

Predictive Factors of Thrombocytopenia in Treatment of Chronic Hepatitis C (CHC) Patients With Peginterferon Alfa-2a (40KD) and Ribavirin

Gastroenterology (New York, N.Y. 1943), 2011, Vol.140 (5), p.S-948-S-948

2011

Link zum Volltext

Verfügbarkeit prüfen

Iron, the HFE gene, and hepatitis C

Clinics in liver disease, 2004-11, Vol.8 (4), p.775

2004

Link zum Volltext

Verfügbarkeit prüfen

Contributing and Terminating Factors of a Large RSV Outbreak in an Adult Hematology and Transplant Unit

PLoS currents, 2014-09, Vol.6

RSV Outbreak Investigation Team, *

2014

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Publisher Correction to: Safety, effectiveness and mid-term follow-up in 136 consecutive patients with moderate to severely calcified lesions undergoing phoenix atherectomy

Truncating mutations in the Wilson disease gene ATP7B are associated with very low serum ceruloplasmin oxidase activity and an early onset of Wilson disease

Outcomes and Costs of Treating Hepatitis C Patients in the Era of First Generation Protease Inhibitors - Results from the PAN Study

Changes in severity of influenza A(H1N1)pdm09 infection from pandemic to first postpandemic season, Germany

Sensitivity and specificity of plasma disappearance rate of indocyanine green as a prognostic indicator in acute liver failure

Chronic hepatitis E virus infection in a patient with leukemia and elevated transaminases: a case report

Fatal Course of a Suicidal Intoxication with Hydrochloric Acid

Diagnostic Pathway From Incidental Mass to Metastatic Melanoma: Role of Multimodal Imaging and Medical Therapy

Diagnostic Pathway From Incidental Mass to Metastatic Melanoma

HFE Gene Mutations, Iron Overload and Cryptogenic Liver Cirrhosis

Changes in severity of influenza Apdm09 infection from pandemic to first postpandemic season, Germany

Pharmacodynamic monitoring of immunosuppressive effects indicates reduced cyclosporine activity during telaprevir therapy: NFAT in Liver Allograft Recipients on Telaprevir

An orthotopic colon cancer model for studying the B7-H3 antitumor effect in vivo

723 Substantial Renal Impairment Is Not Infrequent in HCV Patients Under Triple Therapy With Telaprevir or Boceprevir

Outbreak of Nosocomial Respiratory Syncytial Virus Infections in a Hematology and Transplant Unit

Sa1050 Efficacy of Boceprevir Based Triple Therapy in Combination With Peginterferon-Alfa-2A Plus Ribavirin (P/R) Under Real Life Conditions in Treatment Experienced Patients Infected With Chronic Hepatitis C, Genotype 1: The PAN Study

Sa1041 Triple Therapy Under Real Life Conditions: Telaprevir (TVR) and Boceprevir (BOC) in Combination With Peginterferon-Alfa-2A Plus Ribavirin (P/R) in Treatment Experienced Patients Infected With Chronic Hepatitis C, Genotype 1. the PAN Study

Sa1051 Boceprevir Based Triple Therapy in Combination With Peginterferon-Alfa-2A Plus Ribavirin (P/R) Under Real Life Conditions in Treatment NaïVE Patients Infected With Chronic Hepatitis C, Genotype 1: An Interim Analysis At Week 12 After Start of Treatment

Sa1052 Triple Therapy Under Real Life Conditions: Telaprevir (TVR) in Combination With Peginterferon-Alfa-2A Plus Ribavirin (P/R) in NaïVE Patients Infected With Chronic Hepatitis C, Genotype 1. The PAN Study

Sa1058 Change of Treatment Patterns Over a Decade of Dual Therapy of Chronic Hepatitis C (CHC) With Peginterferon Alfa-2A (PEG) and Ribavirin (RBV)

Sa1059 Viral Response at Week 2 as a Predicitive Factor for Rvr in Chronic Hepatitis C Genotype 1 Infection Treated With Peginterferon Alfa-2A (PEG) and Ribavirin (RBV)

Dose Reduction of Peginterferon Alfa-2a (PEG) in Combination With Ribavirin (RBV) in Chronic Hepatitis C (CHC) Patients: Impact on Virological Response Under Real Life Conditions

Predictive Factors of Thrombocytopenia in Treatment of Chronic Hepatitis C (CHC) Patients With Peginterferon Alfa-2a (40KD) and Ribavirin

Iron, the HFE gene, and hepatitis C

Contributing and Terminating Factors of a Large RSV Outbreak in an Adult Hematology and Transplant Unit

Aktive Filter

Suchergebnisse filtern